| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |